Tech Company Financing Transactions
Avera Pharmaceuticals Funding Round
On 8/3/2004, Avera Pharmaceuticals landed $48 million in Series C funding from Aberdare Ventures, Bay City Capital and Frazier Healthcare Partners.
Transaction Overview
Company Name
Announced On
8/3/2004
Transaction Type
Venture Equity
Amount
$48,000,000
Round
Series C
Proceeds Purpose
The proceeds of this financing will provide the capital necessary to achieve significant value-creating clinical milestones for each of our initial drug candidates.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4350 La Jolla Village Dr. 450
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Website
Email Address
Overview
Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dinu Sen
Chief Medical Officer
Barney King
Chief Scientific Officer
William Pitlick
Browse more venture capital transactions:
Prev: 8/2/2004: Mirage Networks venture capital transaction
Next: 8/3/2004: Serenex venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs